Lentivirus (LV)-mediated gene HSPC therapy was shown to improve or completely treat the disease in several animal models of neurological LSDs and is now approved for patients with metachromatic leukodystrophy [13,34,35,41,42,43]. This evidence concerns the gene PSMA7 and metachromatic leukodystrophy.